Prof. Dr. Oliver Schwarz

Studiendekan Business Analytics, Controlling & Consulting

Telefon: +49 791 946 313 40

E-Mail: oliver.schwarz@hs-heilbronn.de

Besuchsadresse: A110 Campus Schwäbisch Hall

Postadresse: Ziegeleiweg 4, 74523 Schwäbisch Hall

Sprechzeiten: nach Vereinbarung

M. Schlander, D. Hernandez, O. Schwarz, R. Schaefer: PP74 Are Commonly Used Cost-Effectiveness Thresholds Too Low? Empirical Evidence From Economic Studies On The Value Of Life. International Journal of Technology Assessment in Health Care. 2024;40(S1): S85-S85. doi:10.1017/S0266462324002435
M.. Schlander, R. Schaefer, O. Schwarz, J. Richardson: Can we predict the Impact of Diffferential Sensitivity of Health-Related Quality of Life (HRQOL) Instruments on the Valuation of Health State Changes?, Value in Health, Volume 27, Issue 6, June 2024, Supplement S261
M. Schlander, O. Schwarz, ∙D. Hernandez,∙R. Schaefer,: HPR140 Are North Americans Willing-to-Pay More for Life and Limb?, Value in Health, Volume 27, Issue 6, June 2024, Supplement S218
M. Schlander, O. Schwarz, D. Hernandez, R. Schaefer: What Is a Year of Life Worth? Empirical Findings from Worldwide Economic Studies on the Value of a Statistical Life. Value in Health, Volume 26, Issue 12, 2023 S277
O. Schwarz: Datenanalyse- Einführung, deskriptive und diagnostische Analyse, in: Lang, M (Hrsg): Datenkompetenz – Daten erfolgreich nutzen, Carl Hanser Verlag, München 2023, 2023, S. 85-116
O. Schwarz: Datenanalyse- prädiktive und präskriptive Analyse, in: Lang, M (Hrsg) Datenkompetenz – Daten erfolgreich nutzen, Carl Hanser Verlag, München 2023, S. 117 -146
M. Schlander, O. Schwarz, D. Hernandez, R. Schaefer: New Estimates of the Willingness-to-Pay for a Statistical Life Year: A Systematic Review of the Empirical Economic Literature. Value in Health [21] (2018), S.111
R. Schaefer, O. Schwarz, M. Schlander: Empirical Studies On The Economic Value Of A Statistical Life Year (VSLY) In Europe: What Do They Tell Us?. Value in Health [9] (2017), A666
R. Schaefer, O. Schwarz, M. Schlander: “Appraising the Appraisers”: Do National Health Technology Assessment Agencies (NICE, GBA/IQWIG) Follow Their Official Evaluation Criteria?. Value in Health [9] (2017), A410
R. Schaefer, O. Schwarz, M. Schlander: OP95 An Update On The Economic Value Of A Statistical Life Year In Europe. International Journal of Technology Assessment in Health Care 33(S1): 44, January 2017
O. Schwarz, R. Schaefer , M. Schlander: VP95 The Monetary Value Of A Statistical Life Year: A Systematic Review. International Journal of Technology Assessment in Health Care 33(S1): 192-193, January 2017
T. Bernecker, O. Schwarz, E. Winter, S. Raiber: Logistikinnovationen Baden-Württemberg – Eine EInschätzung aus Verlader- und Dienstleistersicht, Fraunhofer-Institut für Arbeitswirtschaft und Organisation IAO, Stuttgart 2016
M. Schlander, O. Schwarz, G.-E. Trott, T. Banaschewski: Mental Health Disorder Prevalence Trends In Germany: A Longitudinal Analysis. Value in Health [7] (2015), A408
M. Schlander, O. Schwarz, G.-E. Trott, T. Banaschewski: Attention-Deficit Hyperactivity Disorder (ADHD), 2003-2009: A Longitudinal Analysis of Prevalence, Health Care and Direct Cost Based upon Administrative Data from Nordbaden / Germany. Symposium. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S102 (Abstract No. S2-06-05).
O. Schwarz, M. Schlander: Mental Health Care Research in Germany: Sociodemographic Characteristics of the Nordbaden Database. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S100 (Abstract No. S2-06-01).
G.-E. Trott, O. Schwarz, T. Banaschewski, W. Scheller, M. Viapiano, N. Bonauer, M. Schlander: The Rising Administrative Prevalence of Attention-Deficit Hyperactivity Disorder (ADHD) in Nordbaden /Germany and Specialist Involvement in Health Care Provision. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S101-102 (Abstract No. S2-06-04).
T. Banaschewski, O. Schwarz, G.-E. Trott, W. Scheller, M. Viapiano, N. Bonauer, M. Schlander: The Evolving Treatment Patterns for Attention-Deficit Hyperactivity Disorder (ADHD) in Nordbaden /Germany: A Retrospective Study Based upon Administrative Data, Years 2003-2009. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S101 (Abstract No. S2-06-03).
M. Schlander, O. Schwarz, G.-E. Trott, T. Banaschewski, W. Scheller, M. Viapiano, N. Bonauer: The Medical Cost Attributable to Attention-Deficit Hyperactivity Disorder (ADHD) in Nordbaden / Germany: A Study From a Health Care Payer’s Perspective Based on Claims Data. European Child + Adolescent Psychiatry 22 [Suppl. 2] (2013) S100-101 (Abstract No. S2-06-02).
M. Schlander, G.E. Trott, T. Banaschewski, O. Schwarz: New Estimates of the Direct Medical Cost of Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany. Value in Health Vol. 16 Issue 7 (2013), Page A546
M. Schlander, T. Banaschewski, G.E. Trott, O. Schwarz: Medication Treatment and Health Care Utilization for Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany. Value in Health Vol. 16, Issue 7 (2013), Page A340
M. Schlander, O. Schwarz: Health Care Utilization Research in Germany: Characterization of the Nordbaden Database. 15th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Berlin / Germany, November 03-07, 2012. Value in Health 15 [7] (2012) page A303.
M. Schlander, O. Schwarz, G.-E. Trott, T. Banaschewski, W. Scheller, M. Viapiano, N. Bonauer: Most Frequently Diagnosed Mental Health Problems in a German Population. 15th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Berlin / Germany, November 03-07, 2012. Value in Health 15 [7] (2012) Page A344.
M. Schlander, O. Schwarz, T. Banaschewski, G.-E. Trott, M. Viapiano, N. Bonauer, W. Scheller: Involvement of CNC Specialists in Health Care Provision for Patients with Attention-Deficit / Hyperactivity Disorder (ADHD): New Data from Nordbaden, Germany, 2003 – 2009. 15th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Berlin / Germany, November 03-07, 2012. Value in Health 15 [7] (2012) Page A535.
M. Schlander, O. Schwarz, G,-E. Trott, T. Banaschewski, M. Viapiano, N. Bonauer: Increasing Use of Medication for Treatment of Attention Deficit hyperactivity Disorder (ADHD) in Germany between 2003 and 2009. 14th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Madrid / Spain, November 05-08, 2011. Value in Health 14 [7] (2011) Page A300.
M. Schlander, A. Philipsen, O. Schwarz, and the COMPAS Study Group: The Cost Effectiveness of Clinically Proven Treatment Strategies for ADHD in Adult Patients. 14th Annual European Congress of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), Madrid / Spain, November 05-08, 2011. Value in Health 14 [7] (2011) A403.
M. Schlander, O. Schwarz, A. Rothenberger, V. Roessner: Tic disorders: prevalence and co-occurrence with attention-deficit/hyperactivity disorder in a German community sample. European Psychiatry, 2011, Volume 26, Issue 6, S. 370-374
M. Schlander, O. Schwarz, G.E. Trott, T. Banaschewski, W. Scheller, M. Viapiano, N. Bonauer: Increasing Administrative prevalence of Attention-Deficit/Hyperactivity Disorder (ADHD) in Germany: Evidence from Nordbaden, 2003 to 2008. Value in Health 13 [7] (2010) A446
M. Schlander, G.-E. Trott, O. Schwarz: Gesundheitsökonomie der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung (ADHS) in Deutschland – Teil 2: Therapeutische Optionen und ihre Kosteneffektivität. Der Nervenarzt, 2010, Volume 81 (3), S. 301 - 314
M. Schlander, G.-E. Trott, O. Schwarz: Gesundheitsökonomie der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung (ADHS) in Deutschland – Teil 1: Versorgungsepidemiologie und Krankheitskosten. Der Nervenarzt, 2010, Volume 81 (3), S, 289-300
O. Schwarz: Absicherung des Net Promoter Score - die Ermittlung von Konfidenzintervallen mit dem Bootstrap Verfahren. Der Markt – Journal für Marketing, 48 (3), 2009, S. 105 - 115